David E Swayne Selected Research

Influenza in Birds (Avian Flu)

1/2021	Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
1/2021	Efficacy of two vaccines against recent emergent antigenic variants of clade 2.3.2.1a highly pathogenic avian influenza viruses in Bangladesh.
1/2021	Pathobiological Origins and Evolutionary History of Highly Pathogenic Avian Influenza Viruses.
11/2020	Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
1/2020	Laboratory Methods for Assessing and Licensing Influenza Vaccines for Poultry.
1/2020	Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses.
1/2020	Protection of White Leghorn chickens by recombinant fowlpox vector vaccine with an updated H5 insert against Mexican H5N2 avian influenza viruses.
10/2019	Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.
1/2019	Rapid evolution of Mexican H7N3 highly pathogenic avian influenza viruses in poultry.
10/2018	Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David E Swayne Research Topics

Disease

52	Influenza in Birds (Avian Flu) 01/2021 - 01/2004
21	Infections 01/2016 - 01/2002
18	Human Influenza (Influenza) 01/2021 - 01/2002
9	Fowlpox 01/2020 - 03/2005
5	Virus Diseases (Viral Diseases) 01/2011 - 09/2004
4	Newcastle Disease 01/2020 - 12/2012
1	Marek Disease (Marek's Disease) 01/2021
1	Necrosis 11/2019
1	Hemorrhage 01/2018
1	Enteritis 01/2014
1	Acute-Phase Reaction 12/2010
1	Inflammation (Inflammations) 08/2010
1	Weight Loss (Weight Reduction) 05/2010
1	Lymphopenia (Lymphocytopenia) 05/2010
1	Dengue (Dengue Fever) 09/2006
1	Viremia 09/2006
1	Pneumonia (Pneumonitis) 12/2005

Drug/Important Bio-Agent (IBA)

44	VaccinesIBA 01/2021 - 01/2004
19	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 09/2004
8	Neuraminidase (Sialidase)IBA 04/2015 - 09/2004
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2005
6	avian influenza A virus hemagglutininIBA 07/2015 - 11/2005
4	AntigensIBA 01/2021 - 11/2005
4	Antiviral Agents (Antivirals)IBA 09/2014 - 10/2006
3	Viral AntigensIBA 11/2019 - 01/2002
3	NucleotidesIBA 01/2019 - 12/2005
3	AntibodiesIBA 10/2014 - 10/2006
3	InterferonsIBA 01/2014 - 02/2007
3	CytokinesIBA 12/2010 - 09/2004
2	Amino Acids FDA Link 01/2021 - 12/2005
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 01/2004
2	ChlorineIBA 11/2009 - 10/2007
2	AgarIBA 09/2007 - 10/2006
1	Basic Amino Acids (Basic Amino Acid)IBA 01/2021
1	PlasticsIBA 01/2018
1	Inactivated VaccinesIBA 04/2015
1	Biological ProductsIBA 01/2015
1	EmulsionsIBA 08/2013
1	Neutralizing AntibodiesIBA 07/2011
1	Influenza Vaccines (Influenza Vaccine)FDA Link 07/2011
1	RNA (Ribonucleic Acid)IBA 07/2011
1	Complement System Proteins (Complement)IBA 12/2010
1	Interleukin-1 (Interleukin 1)IBA 12/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2010
1	AerosolsIBA 09/2010
1	LipoxinsIBA 08/2010
1	ChemokinesIBA 05/2010
1	Interferon-betaIBA 06/2009
1	Interferon Type IIBA 06/2009
1	Interferon-alpha (Interferon Alfa)IBA 04/2009
1	Peptides (Polypeptides)IBA 01/2008
1	HN ProteinIBA 01/2008
1	Indicators and Reagents (Reagents)IBA 10/2007
1	BuffersIBA 10/2007
1	EnzymesIBA 10/2006
1	ImmunosorbentsIBA 10/2006
1	Matrix-MIBA 12/2005
1	NucleoproteinsIBA 12/2005
1	Glycoproteins (Glycoprotein)IBA 12/2005
1	TrypsinIBA 10/2005
1	Complementary DNA (cDNA)IBA 09/2004

Therapy/Procedure

3	Therapeutics 09/2014 - 10/2006